IN2014DN10924A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10924A
IN2014DN10924A IN10924DEN2014A IN2014DN10924A IN 2014DN10924 A IN2014DN10924 A IN 2014DN10924A IN 10924DEN2014 A IN10924DEN2014 A IN 10924DEN2014A IN 2014DN10924 A IN2014DN10924 A IN 2014DN10924A
Authority
IN
India
Prior art keywords
integer equal
emulsion
acid
tétracarboxylate
gênerai
Prior art date
Application number
Other languages
English (en)
Inventor
JOëL BLOMET
Laurence Mathieu
Marie Claude Meyer
Original Assignee
Prevor Internat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevor Internat filed Critical Prevor Internat
Publication of IN2014DN10924A publication Critical patent/IN2014DN10924A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN10924DEN2014 2012-07-18 2013-07-17 IN2014DN10924A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1256939A FR2993466B1 (fr) 2012-07-18 2012-07-18 Utilisation d'une creme de protection contre les effets des agents chimiques agressifs en contact avec la peau
PCT/FR2013/051717 WO2014013194A1 (fr) 2012-07-18 2013-07-17 Utilisation d'une creme de protection contre les effets des agents chimiques agressifs en contact avec la peau

Publications (1)

Publication Number Publication Date
IN2014DN10924A true IN2014DN10924A (fr) 2015-09-18

Family

ID=47137836

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10924DEN2014 IN2014DN10924A (fr) 2012-07-18 2013-07-17

Country Status (18)

Country Link
US (3) US11197874B2 (fr)
EP (2) EP2874661B1 (fr)
CN (4) CN104470501A (fr)
AU (2) AU2013291793B2 (fr)
BR (2) BR112015001019B1 (fr)
CA (2) CA2878650C (fr)
DK (2) DK2874661T3 (fr)
ES (2) ES2690060T3 (fr)
FR (1) FR2993466B1 (fr)
IN (1) IN2014DN10924A (fr)
MX (2) MX356811B (fr)
NO (1) NO2874604T3 (fr)
NZ (2) NZ703409A (fr)
PL (2) PL2874661T3 (fr)
PT (1) PT2874604T (fr)
SI (1) SI2874661T1 (fr)
TR (1) TR201815143T4 (fr)
WO (2) WO2014013194A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3093001B1 (fr) * 2019-02-22 2022-06-10 Prevor Int Composition pour enlever des residus chimiques et ses utilisations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604900B1 (fr) * 1986-10-08 1989-01-13 Blomet Marie Claude Solution physiologique pour le lavage des parties du corps humain ayant ete mises en contact avec un acide fluorhydrique et concentre pour sa preparation
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5587400A (en) * 1993-04-19 1996-12-24 Marie-Claude Blomet epouse Meyer Physiological composition for the treatment of thermal or chemical burns
US5665804A (en) * 1996-02-05 1997-09-09 Dow Corning Corporation Silicone latex solvent thickening
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US6242042B1 (en) * 1998-09-14 2001-06-05 Lrc Products Ltd. Aqueous coating composition and method
US6582683B2 (en) * 2000-01-04 2003-06-24 Skinvisible Pharmaceuticals, Inc. Dermal barrier composition
FR2809959B1 (fr) * 2000-06-07 2004-10-29 Marie Claude Meyer Utilisation d'un complexe d'aluminium et de ligand ethylenediamine-tetraacetique pour la prevention et/ou le traitement des urticaires
GB0403702D0 (en) * 2004-02-19 2004-03-24 Boots Co Plc Skincare compositions
US20070232681A1 (en) * 2003-10-14 2007-10-04 Oxagen Limited Compounds Having Crth2 Antagonist Activity
GB0324084D0 (en) * 2003-10-14 2003-11-19 Oxagen Ltd Compounds
EP1851669B1 (fr) * 2005-02-02 2015-07-08 POCRASS, Alan L. Dispositif de memoire et de transfert de donnees, et procede correspondant
EP2238183B1 (fr) * 2008-01-18 2019-02-27 Vystar Corporation Latex de caoutchouc naturel ayant une allergénicité réduite et son procédé de fabrication
WO2011041680A2 (fr) * 2009-10-02 2011-04-07 The Brigham And Women's Hospital, Inc. Compositions et procédés de prophylaxie pour l'eczéma de contact

Also Published As

Publication number Publication date
EP2874661A1 (fr) 2015-05-27
US10953024B2 (en) 2021-03-23
BR112015001019A2 (pt) 2017-06-27
BR112015001019B1 (pt) 2022-07-19
EP2874604A1 (fr) 2015-05-27
CN104507501A (zh) 2015-04-08
FR2993466A1 (fr) 2014-01-24
CA2878882A1 (fr) 2014-01-23
PL2874604T3 (pl) 2018-07-31
CN108606964A (zh) 2018-10-02
DK2874661T3 (en) 2018-11-05
US20150190357A1 (en) 2015-07-09
CA2878882C (fr) 2020-08-18
US11197874B2 (en) 2021-12-14
TR201815143T4 (tr) 2018-11-21
WO2014013195A1 (fr) 2014-01-23
DK2874604T3 (en) 2018-05-22
FR2993466B1 (fr) 2014-08-15
NZ703409A (en) 2016-11-25
EP2874604B1 (fr) 2018-02-14
PL2874661T3 (pl) 2018-12-31
US20210275553A1 (en) 2021-09-09
MX356811B (es) 2018-06-13
PT2874604T (pt) 2018-05-11
BR112015001018B1 (pt) 2021-09-08
AU2013291793B2 (en) 2017-11-23
CA2878650C (fr) 2020-07-21
MX2015000785A (es) 2015-09-16
MX2015000786A (es) 2015-09-16
CN104470501A (zh) 2015-03-25
ES2690060T3 (es) 2018-11-19
US20150202217A1 (en) 2015-07-23
AU2013291793A1 (en) 2015-01-22
CA2878650A1 (fr) 2014-01-23
WO2014013194A1 (fr) 2014-01-23
MX359747B (es) 2018-10-08
AU2013291792A1 (en) 2015-01-22
SI2874661T1 (sl) 2018-11-30
ES2667709T3 (es) 2018-05-14
NO2874604T3 (fr) 2018-07-14
CN110179686A (zh) 2019-08-30
NZ703258A (en) 2016-11-25
BR112015001018A2 (pt) 2017-06-27
AU2013291792B2 (en) 2017-11-09
EP2874661B1 (fr) 2018-08-08

Similar Documents

Publication Publication Date Title
HK1254470A1 (zh) 3'平伏氟取代的神經氨酸酶抑制劑化合物、組合物及其用作抗病毒劑的方法
PH12014502397A1 (en) Pesticidal compositions and processes related thereto
MX346665B (es) Composiciones pesticidas y procedimientos relacionados con estas.
PH12014502396B1 (en) Nitrogenated heterocyclic compound
TN2015000245A1 (en) Heterocyclic compound
MX2014005096A (es) Composiciones plaguicidas y procesos relacionados con dichas composiciones.
BR112013020767A2 (pt) composições compreendendo ácido peróxi alfa-cetocarboxílico e métodos para a produção e o uso do mesmo
MX363987B (es) Sales de n-(tetrazol-5-il)- y n-(triazol-5-il)arilcarboxamida y uso de las mismas como herbicidas.
WO2013076316A3 (fr) Composés substitués de n-(tétrazol-5-yl)- et n-(triazol-5-yl) hétarylcarboxamides et leur utilisation comme herbicides
WO2012034680A3 (fr) Mélanges phosphorés, procédés pour les préparer et utilisation desdits mélanges phosphorés
SG191068A1 (en) New form of administration of enkephalinase inhibitor
IN2014DN05818A (fr)
IN2014CN00981A (fr)
WO2012104240A3 (fr) Utilisation cosmétique
BR112015026840A2 (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, uso de um composto, e, método prevenir ou tratar hiperfosfatemia
HK1199455A1 (en) Polycyclic aromatic compounds containing an s atom or s(=0)2 group and their use as dyes s s(=o)2
MX343540B (es) Compuesto de tiazol y metodo de preparacion y uso del mismo.
MX2014001623A (es) Uso de la cardiotofina-1 para el tratamiento de enfermedades renales.
IN2014DN10924A (fr)
IN2014DN10658A (fr)
LV14606A (lv) Jauns XII faktora inhibitors
WO2011097027A3 (fr) Nouveaux procédés et nouvelles utilités
PH12015500708A1 (en) Agent for enhancing immunity containing glutathione
MY173734A (en) Method and formulation for chemical peeling
MX2011012511A (es) Anti-oomicetos.